Clinical trials: Endothelial Dysfunction
- Condition Endothelial Dysfunction
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Sickle Cell Disease
A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease
This Phase 2a, multicenter, open-label, dose-escalation study is designed to assess the safety and biologic activity of daily oral administration of 4 escalating doses of sapropterin dihydrochloride over 16 weeks in subjects with…
- Trial name
- NCT00445978
- Testing
- Sapropterin Dihydrochloride
- Where
- 12 sites in United States
- Volunteers
- 32 people
- Sponsor
- BioMarin Pharmaceutical
Endothelial Dysfunction
Bioefficacy of Phenolic Acids
The objective is to demonstrate the effect of phenolic acids on endothelial function.
- Trial name
- NCT01781559
- Testing
- phenolic acid
- Where
- Australia
- Volunteers
- 14 people, healthy volunteers welcome
- Sponsor
- Société des Produits Nestlé (SPN)